Sebacic Acid From China, 28572-28573 [05-9839]
Download as PDF
<![CDATA[
28572
Federal Register / Vol. 70, No. 95 / Wednesday, May 18, 2005 / Notices
working group’s Designated Federal
Official.
SUPPLEMENTARY INFORMATION:
For
background information and questions
regarding the Trinity River Restoration
Program, please contact Douglas
Schleusner, Executive Director, Trinity
River Restoration Program, P.O. Box
1300, 1313 South Main Street,
Weaverville, California 96093, (530)
623–1800.
SUPPLEMENTARY INFORMATION:
Dated: May 12, 2005.
John Engbring,
Acting Manager, California/Nevada
Operations Office, Sacramento, CA.
[FR Doc. 05–9888 Filed 5–17–05; 8:45 am]
BILLING CODE 4310–55–P
DEPARTMENT OF THE INTERIOR
Bureau of Indian Affairs
Amendment to Notice of Intent To
Prepare an Environmental Impact
Statement for the Pueblo of Jemez’s
Proposed Trust Acquisition and
Casino Project, Dona Ana County, New
Mexico
Bureau of Indian Affairs,
Interior.
ACTION: Notice.
AGENCY:
SUMMARY: This notice advises the public
that the Bureau of Indian Affairs (BIA)
is amending its Notice of Intent to
Prepare an Environmental Impact
Statement (EIS) for the Pueblo of
Jemez’s Proposed Trust Acquisition and
Casino Project, Dona Ana County, New
Mexico, published in the Federal
Register on March 1, 2005 (70 FR 9963–
9964), which described the proposed
action. In response to a request by an
interested party, and in the interest of
providing the public the fullest
reasonable opportunity to participate in
the scoping process for this EIS, this
amendment reopens the public
comment period for an additional 30
days.
Written comments on the scope
of the EIS or implementation of the
proposal must arrive by June 17, 2005.
ADDRESSES: You may mail or hand carry
written comments to Mr. Larry Morrin,
Regional Director, Southwest Regional
Office, Bureau of Indian Affairs, P.O.
Box 26567, Albuquerque, New Mexico
87125. Please include your name, return
address, and the caption, ‘‘DEIS Scoping
Comments, Pueblo of Jemez Trust
Acquisition and Casino Project,’’ on the
first page of your written comments.
FOR FURTHER INFORMATION CONTACT:
Dawn Selwyn, (505) 563–3106.
DATES:
VerDate jul<14>2003
14:03 May 17, 2005
Jkt 205001
Comments, including names and
addresses of respondents, will be
available for public review at the BIA
address shown in the ADDRESSES
section, during business hours, 8 a.m. to
4:30 p.m., Monday through Friday,
except holidays. Individual respondents
may request confidentiality. If you wish
us to withhold your name and/or
address from public review or from
disclosure under the Freedom of
Information Act, you must state this
prominently at the beginning of your
written comment. Such requests will be
honored to the extent allowed by the
law. We will not, however, consider
anonymous comments. All submissions
from organizations or businesses, and
from individuals identifying themselves
as representatives or officials of
organizations or businesses, will be
made available for public inspection in
their entirety.
This notice is published in
accordance with section 1503.1 of the
Council of Environmental Quality
Regulations (40 CFR parts 1500 through
1508) implementing the procedural
requirements of the National
Environmental Policy Act of 1969, as
amended (42 U.S.C. 4371 et seq.),
Department of the Interior Manual (516
DM 1–6), and is in the exercise of
authority delegated to the Principal
Deputy Assistant Secretary—Indian
Affairs by 209 DM 8.l.
Dated: May 6, 2005.
Michael D. Olsen,
Principal Deputy Assistant Secretary—Indian
Affairs.
[FR Doc. 05–9846 Filed 5–17–05; 8:45 am]
BILLING CODE 4310–W7–P
Bureau of Land Management
[AK964–1410–HY–P; AA–6669–C, AA–6669–
K, BBA–3]
Alaska Native Claims Selection
Bureau of Land Management,
Interior.
ACTION: Notice of decision approving
lands for conveyance.
AGENCY:
SUMMARY: As required by 43 CFR
2650.7(d), notice is hereby given that an
appealable decision approving lands for
conveyance pursuant to the Alaska
Native Claims Settlement Act, will be
issued to Igiugig Native Corporation.
The lands are located in Lot 9, U.S.
Survey No. 7982, Alaska, and T. 10 S.,
Rs. 37 and 41 W., Seward Meridian,
Alaska, in the vicinity of Igiugig, Alaska,
and contains 4,302.30 acres. Notice of
Frm 00067
Fmt 4703
John Leaf,
Land Law Examiner, Branch of Adjudication
II.
[FR Doc. 05–9844 Filed 5–17–05; 8:45 am]
BILLING CODE 4310–$$–P
INTERNATIONAL TRADE
COMMISSION
[Investigation No. 731–TA–653 (Second
Review)]
Sebacic Acid From China
DEPARTMENT OF THE INTERIOR
PO 00000
the decision will also be published four
times in the Anchorage Daily News.
DATES: The time limits for filing an
appeal are:
1. Any party claiming a property
interest which is adversely affected by
the decision shall have until June 17,
2005 to file an appeal.
2. Parties receiving service of the
decision by certified mail shall have 30
days from the date of receipt to file an
appeal.
Parties who do not file an appeal in
accordance with the requirements of 43
CFR Part 4, Subpart E, shall be deemed
to have waived their rights.
ADDRESSES: A copy of the decision may
be obtained from: Bureau of Land
Management, Alaska State Office, 222
West Seventh Avenue, #13, Anchorage,
Alaska 99513–7599.
FOR FURTHER INFORMATION, CONTACT:
John Leaf, by phone at (907) 271–3283,
or by e-mail at John_Leaf@ak.blm.gov.
Persons who use a telecommunication
device (TTD) may call the Federal
Information Relay Service (FIRS) at 1–
800–877–8330, 24 hours a day, seven
days a week, to contact Mr. Leaf.
Sfmt 4703
Determination
On the basis of the record 1 developed
in the subject five-year review, the
United States International Trade
Commission (Commission) determines,
pursuant to section 751(c) of the Tariff
Act of 1930 (19 U.S.C. 1675(c)) (the
Act), that revocation of the antidumping
duty order on sebacic acid from China
would not be likely to lead to
continuation or recurrence of material
injury to an industry in the United
States within a reasonably foreseeable
time.
Background
The Commission instituted this
review on April 1, 2004 (69 FR 17233)
and determined on July 6, 2004 that it
would conduct a full review (69 FR
1 The record is defined in § 207.2(f) of the
Commission’s Rules of Practice and Procedure (19
CFR 207.2(f)).
E:\FR\FM\18MYN1.SGM
18MYN1
Federal Register / Vol. 70, No. 95 / Wednesday, May 18, 2005 / Notices
45075, July 28, 2004). Notice of the
scheduling of the Commission’s review
and of a public hearing to be held in
connection therewith was given by
posting copies of the notice in the Office
of the Secretary, U.S. International
Trade Commission, Washington, DC,
and by publishing the notice in the
Federal Register on July 28, 2004 (69 FR
45075). Notice of cancellation of the
public hearing scheduled in connection
with this review (due to lack of interest)
was published in the Federal Register
on December 7, 2004 (69 FR 70705).
Notice of the revised scheduling of the
review was published in the Federal
Register on January 28, 2005 (70 FR
4150).
The Commission transmitted its
determination in this review to the
Secretary of Commerce on May 11,
2005. The views of the Commission are
contained in USITC Publication 3775
(May 2005), entitled Sebacic Acid from
China: Investigation No. 731–TA–653
(Second Review).
Issued: May 11, 2005.
By order of the Commission.
Marilyn R. Abbott,
Secretary to the Commission.
[FR Doc. 05–9839 Filed 5–17–05; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
A–1 Distribution Wholesale; Denial of
Registration
On October 8, 2004, the Deputy
Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration (DEA), issued an Order
to Show Cause to A–1 Distribution
Wholesale (A–1) proposing to deny its
September 19, 2002, application for
DEA Certificate of Registration as a
distributor of list I chemicals. The Order
to Show Cause alleged that granting
A–1’s application would be inconsistent
with the public interest, as that term is
used in 21 U.S.C. 823(h). The order also
notified A–1 that should no request for
a hearing be filed within 30 days, its
hearing right would be deemed waived.
According to the DEA investigative
file, the Order to Show Cause was sent
by certified mail to A–1 at its proposed
registered location at 6751 Macon Road,
Suite 18, Columbus, Georgia 31909. It
was then forwarded by the U.S. Postal
Service to A–1’s new address at 7565
Chattsworth Road, Midland, Georgia
31820–4026, where it was received on
October 18, 2004. DEA has not received
a request for a hearing or any other reply
VerDate jul<14>2003
14:03 May 17, 2005
Jkt 205001
from A–1 or anyone purporting to
represent the company in this matter.
Therefore, the Deputy Administrator
of DEA, finding that (1) thirty days have
passed since delivery of the Order to
Show Cause, and (2) no request for a
hearing having been received, concludes
that A–1 has waived its hearing right.
See Aqui Enterprises, 67 FR 12,576
(2002). After considering relevant
material from the investigative file, the
Deputy Administrator now enters her
final order without a hearing pursuant
to 21 CFR 1309.53(c) and (d) and
1316.67. The Deputy Administrator
finds as follows.
List I chemicals are those that may be
used in the manufacture of a controlled
substance in violation of the Controlled
Substances Act. 21 U.S.C. 802(34); 21
CFR 1310.02(a). Pseudoephedrine and
ephedrine are list I chemicals
commonly used to illegally manufacture
methamphetamine, a Schedule II
controlled substance. As noted in
previous DEA final orders,
methamphetamine is an extremely
potent central nervous system
stimulant, and its abuse is a persistent
and growing problem in the United
States. See e.g., Direct Wholesale, 69 FR
11,654 (2004); Branex, Inc., 69 FR 8,682
(2004); Yemen Wholesale Tobacco and
Candy Supply, Inc., 67 FR 9,997 (2002);
Denver Wholesale, 67 FR 99,986 (2002).
The Deputy Administrator’s review of
the investigative file reveals that on or
about September 19, 2002, an
application was submitted by the owner
of A–1, Mr. David Smith, seeking
registration to distribute ephedrine and
pseudoephedrine list I chemical
products. The application originally
included phenylpropanolamine, but
that listed chemical product was
eventually deleted from the request.
In connection with the pending
application, an on-site pre-registration
investigation was conducted at the
proposed premises in April 2003.
Investigators were advised that A–1 was
a sole proprietorship, operated by Mr.
Smith and his wife, with no other
employees. It commenced operations in
June 2002 and was a wholesale
distributor of general merchandise such
as health and beauty aids, automotive
products, sunglasses and other sundry
items. A–1 provided a list of products
it intended to carry which included 60
tablet bottles of Mini Two Way and Two
Way brand combination ephedrine, as
well as Pseudo 60 brand
pseudoephedrine. The majority of A–1’s
proposed customers were gas stations,
small retail markets and convenience
stores in the Columbus, Georgia area.
Neither Mr. Smith nor his wife had any
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
28573
prior experience with the distribution of
list I chemicals.
DEA is aware that small illicit
laboratories operate with listed
chemical products often procured,
legally or illegally, from non-traditional
retailers of over-the-counter drug
products, such as gas stations and small
retail markets. Some retailers acquire
product from multiple distributors to
mask their acquisition of large amounts
of listed chemicals. In addition, some
individuals utilize sham corporations or
fraudulent records to establish a
commercial identity in order to acquire
listed chemicals.
The Deputy Administrator has
previously found that the illegal
production of methamphetamine
continues unabated within the DEA
Atlanta region. The adjacent State of
Tennessee leads the region in the
number of clandestine laboratories
seized, accounting for approximately 50
percent of the clandestine laboratories
seized during the second quarter of
2002. When compared with the third
quarter of 2001, the increase in
clandestine laboratory seizures is
notable. According to later records for
the Atlanta region, 360 clandestine
laboratories were seized during the third
quarter of 2002. Of the 360 laboratories
seized during that reporting period, 207
were located in Tennessee, 103 in
Georgia, 35 in South Carolina and 15 in
North Carolina. See CWK Enterprises,
Inc. (CWK), 69 FR 69,400 (2004); Prachi
Enterprises, Inc. (Prachi), 69 FR 69,407
(2004).
In the State of Georgia, there has been
a consistent increase in the number of
illicit laboratories and enforcement
teams continue to note a trend toward
smaller capacity laboratories. This is
likely due to the ease of concealment
associated with smaller laboratories,
which continue to dominate seizures
and cleanup responses. The adjacent
State of Tennessee also has a substantial
methamphetamine abuse problem in the
Chattanooga and Eastern Tennessee
areas and DEA is aware of a past history
of trafficking in precursors in these
locations. Distributors or retailers
selling the illicit methamphetamine
trade observe no borders and trade
across state lines. In fact, where
precursor laws are stringent, out-of-state
distributors often make direct shipments
to retainers without observing state
requirements. See CKW, supra, 69 FR
69,400; Prachi, supra, 69 FR 69,407.
DEA knows by experience that there
exists a ‘‘gray market’’ in which certain
high strength, high quantity
pseudoephedrine and ephedrine
products are distributed only to
convenience stores and gas stations,
E:\FR\FM\18MYN1.SGM
18MYN1
]]>Agencies
[Federal Register Volume 70, Number 95 (Wednesday, May 18, 2005)]
[Notices]
[Pages 28572-28573]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-9839]
=======================================================================
-----------------------------------------------------------------------
INTERNATIONAL TRADE COMMISSION
[Investigation No. 731-TA-653 (Second Review)]
Sebacic Acid From China
Determination
On the basis of the record \1\ developed in the subject five-year
review, the United States International Trade Commission (Commission)
determines, pursuant to section 751(c) of the Tariff Act of 1930 (19
U.S.C. 1675(c)) (the Act), that revocation of the antidumping duty
order on sebacic acid from China would not be likely to lead to
continuation or recurrence of material injury to an industry in the
United States within a reasonably foreseeable time.
---------------------------------------------------------------------------
\1\ The record is defined in Sec. 207.2(f) of the Commission's
Rules of Practice and Procedure (19 CFR 207.2(f)).
---------------------------------------------------------------------------
Background
The Commission instituted this review on April 1, 2004 (69 FR
17233) and determined on July 6, 2004 that it would conduct a full
review (69 FR
[[Page 28573]]
45075, July 28, 2004). Notice of the scheduling of the Commission's
review and of a public hearing to be held in connection therewith was
given by posting copies of the notice in the Office of the Secretary,
U.S. International Trade Commission, Washington, DC, and by publishing
the notice in the Federal Register on July 28, 2004 (69 FR 45075).
Notice of cancellation of the public hearing scheduled in connection
with this review (due to lack of interest) was published in the Federal
Register on December 7, 2004 (69 FR 70705). Notice of the revised
scheduling of the review was published in the Federal Register on
January 28, 2005 (70 FR 4150).
The Commission transmitted its determination in this review to the
Secretary of Commerce on May 11, 2005. The views of the Commission are
contained in USITC Publication 3775 (May 2005), entitled Sebacic Acid
from China: Investigation No. 731-TA-653 (Second Review).
Issued: May 11, 2005.
By order of the Commission.
Marilyn R. Abbott,
Secretary to the Commission.
[FR Doc. 05-9839 Filed 5-17-05; 8:45 am]
BILLING CODE 7020-02-P
